Drug Profile
EF 27
Alternative Names: Amelorad; So 5407Latest Information Update: 17 Mar 1998
Price :
$50
*
At a glance
- Originator Scotia Pharmaceuticals [CEASED]
- Class Antineoplastics; Radioprotectives
- Mechanism of Action Prostaglandin synthase stimulants; Thromboxane synthase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Radiation injuries
Most Recent Events
- 17 Mar 1998 Scotia has withdrawn EF 27 license application in Europe
- 23 Feb 1998 Discontinued-Clinical for Radiation injuries (Prevention)/Radioprotection in European Union (Unknown route)
- 23 Feb 1998 Discontinued-Clinical for Radiation injuries (Prevention)/Radioprotection in South Africa (Unknown route)